Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China

Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China

PurposeThe study aimed to assess factors associated with early infection and identify patients at high risk of developing infection in multiple myeloma.MethodsThe study retrospectively analyzed patients with MM seen at two medical centers between January 2013 and June 2019. One medical center report...

Full description

Bibliographic Details
Main Authors: Yufeng Shang, Weida Wang, Yuxing Liang, Natasha Mupeta Kaweme, Qian Wang, Minghui Liu, Xiaoqin Chen, Zhongjun Xia, Fuling Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
infection
risk factors
infection model
novel drug
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.772015/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.772015/full

Similar Items